Chargement en cours...
A novel imidazolinone metformin‐methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF‐1α pathway
Peripheral arterial disease (PAD) is one of the major complications of diabetes due to an impairment in angiogenesis. Since there is currently no drug with satisfactory efficacy to enhance blood vessel formation, discovering therapies to improve angiogenesis is critical. An imidazolinone metabolite...
Enregistré dans:
| Publié dans: | FASEB J |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8237315/ https://ncbi.nlm.nih.gov/pubmed/34105824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.202002674RR |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|